Market Tracker

01/17 4:45pm ET

Cytokinetics Inc (NASDAQ:CYTK)

11.00
Delayed Data
As of Jan 17
 -0.85 / -7.17%
Today’s Change
6.00
Today|||52-Week Range
13.45
-9.47%
Year-to-Date
No recent news for Cytokinetics Inc.

Today’s Trading

Previous close11.85
Today’s open11.75
Day’s range10.98 - 11.75
Volume324,816
Average volume (3 months)343,156
Market cap$480.1M
Dividend yield--
Data as of 4:00pm ET, 01/17/2017

Growth & Valuation

Earnings growth (last year)-136.59%
Earnings growth (this year)+77.32%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)-38.95%
P/E ratioNM
Price/Sales14.17
Price/Book6.84

Competitors

 Today’s
change
Today’s
% change
COLLCollegium Pharmaceut...-1.02-6.25%
HRTXHeron Therapeutics I...-0.05-0.39%
OTICOtonomy Inc-0.85-5.07%
CRHMCRH Medical Corp-0.20-3.23%
Data as of 4:02pm ET, 01/17/2017

Financials

Next reporting dateFebruary 7, 2017
EPS forecast (this quarter)-$0.41
Annual revenue (last year)$28.7M
Annual profit (last year)-$37.5M
Net profit margin-130.86%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert I. Blum
Chief Financial Officer, Secretary &
Executive VP
Barabari Sharon A. Surrey
Corporate headquarters
South San Francisco, California

Forecasts